IMPROVEDD Risk Score VTE

VTE Risk Score

The IMPROVEDD Risk Score estimates VTE risk in hospitalized medical patients by combining the IMPROVE model with elevated D‑dimer to enhance prediction accuracy.

Previous VTE?
No0Yes+3
Known thrombophilia?
No0Yes+2
Current lower-limb paralysis?
No0Yes+2
Current cancer?
No0Yes+2
Immobilized?
No0Yes+1
ICU/CCU stay?
No0Yes+1
Age > 60 years?
No0Yes+1
D-dimer ≥ 2x ULN?
No0Yes+2

Indikationen

Used to stratify hospitalized medical patients for in‑hospital VTE risk when considering pharmacologic prophylaxis. Applies to adults with acute medical illness and ≥1 classic IMPROVE VTE risk factors, with D‑dimer added to improve discrimination (validated IMPROVE‑VTE RAM performance summarized in systematic reviews 1 [Level II evidence]). Identifies low‑risk patients who may safely avoid anticoagulant prophylaxis and higher‑risk patients who benefit from pharmacologic VTE prevention.

Hinweise & Vorsichtsmaßnahmen

Identifies hospitalized medical patients at elevated VTE risk using IMPROVE criteria plus elevated D‑dimer, but performance varies and evidence is mostly retrospective. Use cautiously because external validations show modest discrimination for medical inpatients 1 [Level II evidence]. Elevated D‑dimer improves sensitivity but may inflate risk estimates in inflammation-heavy states and increase overtreatment. Not validated for cancer‑specific or COVID‑19 populations.